Patents Assigned to University of Iceland
  • TRITYL-NITROXIDE MULTIRADICALS AS POLARIZING AGENTS FOR DYNMAIC NUCLEAR POLARIZATION
    Publication number: 20240400585
    Abstract: The present invention relates to novel trityl-nitroxide radicals as polarizing agents for Dynamic Nuclear Polarization (DNP).
    Type: Application
    Filed: September 12, 2022
    Publication date: December 5, 2024
    Applicants: Commissariat a l'Energie Atomique et aux Energies Alternatives, University of Iceland, Universite Grenoble Alpes
    Inventors: Gaël DE PAEPE, Rania HARRABI, Frédéric MENTINK-VIGIER, Snorri Th. SIGURDSSON, Thomas HALBRITTER
  • DINITROXIDE BIRADICAL COMPOUNDS AS POLARIZING AGENTS
    Publication number: 20230040736
    Abstract: The present invention relates to novel organic dinitroxide biradical compounds and their use as polarizing agents, in particular, in the techniques of Nuclear Magnetic Resonance (NMR) of solids or liquid samples and medical imaging.
    Type: Application
    Filed: July 18, 2022
    Publication date: February 9, 2023
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, University of Iceland
    Inventors: Gaël De Paepe, Frédéric Mentink-Vigier, Snorri Sigurdsson, Anil Jagtap
  • Dinitroxide biradical compounds as polarizing agents
    Patent number: 11472790
    Abstract: The present invention relates to novel organic dinitroxide biradical compounds and their use as polarizing agents, in particular, in the techniques of Nuclear Magnetic Resonance (NMR) of solids or liquid samples and medical imaging.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: October 18, 2022
    Assignees: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, University of Iceland
    Inventors: Gaël De Paepe, Frédéric Mentink-Vigier, Snorri Sigurdsson, Anil Jagtap
  • DINITROXIDE BIRADICAL COMPOUNDS AS POLARIZING AGENTS
    Publication number: 20200148666
    Abstract: The present invention relates to novel organic dinitroxide biradical compounds and their use as polarizing agents, in particular, in the techniques of Nuclear Magnetic Resonance (NMR) of solids or liquid samples and medical imaging.
    Type: Application
    Filed: July 3, 2018
    Publication date: May 14, 2020
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, University of Iceland
    Inventors: Gaël De Paepe, Frédéric Mentink-Vigier, Snorri Sigurdsson, Anil Jagtap
  • Methods and compositions for the delivery of a therapeutic agent
    Patent number: 8809322
    Abstract: The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example, methoxy-polyethylene glycol, for administration of the therapeutic agent to the mammal. The compositions can be applied to a membrane, for example, a nasal membrane during intranasal administration. The invention also provides methods of administering such compositions to a mammal.
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: August 19, 2014
    Assignees: Hananja EHF, University of Iceland
    Inventor: Sveinbjorn Gizurarson
  • METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT
    Publication number: 20120264745
    Abstract: The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example, methoxy-polyethylene glycol, for administration of the therapeutic agent to the mammal. The compositions can be applied to a membrane, for example, a nasal membrane during intranasal administration. The invention also provides methods of administering such compositions to a mammal.
    Type: Application
    Filed: April 13, 2012
    Publication date: October 18, 2012
    Applicants: University of Iceland, Hananja ehf
    Inventors: Sveinbjorn Gizurarson, James Arp, Raouf Ghaderi, Michael E. Lusty, Gregory G. Plucinski, Mehdi Yazdi
  • Methods and compositions for the delivery of a therapeutic agent
    Patent number: 8217033
    Abstract: The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example, methoxy-polyethylene glycol, for administration of the therapeutic agent to the mammal. The compositions can be applied to a membrane, for example, a nasal membrane during intranasal administration. The invention also provides methods of administering such compositions to a mammal.
    Type: Grant
    Filed: May 20, 2009
    Date of Patent: July 10, 2012
    Assignees: Hananja EHF, University of Iceland
    Inventor: Sveinbjorn Gizurarson